APA (7th ed.) Citation

DM, Z., ZH, Y., YY, Y., YY, Z., & ZQ, L. (2026). From mechanisms to therapies: Exploiting epigenetic and post-translational modifications of mitochondrial quality control in diabetic kidney disease. Frontiers in endocrinology, 17, 1821507. https://doi.org/10.3389/fendo.2026.1821507

Chicago Style (17th ed.) Citation

DM, Zhao, Yan ZH, Yu YY, Zhang YY, and Luan ZQ. "From Mechanisms to Therapies: Exploiting Epigenetic and Post-translational Modifications of Mitochondrial Quality Control in Diabetic Kidney Disease." Frontiers in Endocrinology 17 (2026): 1821507. https://doi.org/10.3389/fendo.2026.1821507.

MLA (9th ed.) Citation

DM, Zhao, et al. "From Mechanisms to Therapies: Exploiting Epigenetic and Post-translational Modifications of Mitochondrial Quality Control in Diabetic Kidney Disease." Frontiers in Endocrinology, vol. 17, 2026, p. 1821507, https://doi.org/10.3389/fendo.2026.1821507.

Warning: These citations may not always be 100% accurate.